Figure S2 from Synergism Between IL21 and Anti-PD-1 Combination Therapy is Underpinned by the Coordinated Reprogramming of the Immune Cellular Network in the Tumor Microenvironment

Wu, Shaoxian; Huang, Hao; Sun, Runzi; Gao, David Shihong; Ye, Fan; Huang, Jianing; Li, Ella; Ni, Andrew; Lu, Kevin GuoKai; Chen, Kong; Jiang, Jingting; Morel, Penelope A.; Zhong, Ziyang; Lu, Binfeng

doi:10.1158/2767-9764.23865563.v1

- No file added yet -

Figure S2 from Synergism Between IL21 and Anti-PD-1 Combination Therapy is Underpinned by the Coordinated Reprogramming of the Immune Cellular Network in the Tumor Microenvironment

journal contribution

posted on 2023-08-04, 14:20 authored by Shaoxian Wu, Hao Huang, Runzi Sun, David Shihong Gao, Fan Ye, Jianing Huang, Ella Li, Andrew Ni, Kevin GuoKai Lu, Kong Chen, Jingting Jiang, Penelope A. Morel, Ziyang Zhong, Binfeng Lu

Supplementary Figure 2. FTY720 injection did not affect on anti-PD-1 anti-tumor effect.

Funding

Anwita Biosciences Inc

History

ARTICLE ABSTRACT

This study reveals how cytokine and checkpoint inhibitor therapy can be combined to increase the efficacy of cancer immunotherapy.

Usage metrics

Keywords

Tumor Microenvironment Immune cells and the microenvironment Cytokines and the microenvironment Immunotherapy Combination immunotherapy Checkpoint blockade

Licence

CC BY

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

Figure S2 from Synergism Between IL21 and Anti-PD-1 Combination Therapy is Underpinned by the Coordinated Reprogramming of the Immune Cellular Network in the Tumor Microenvironment

Funding

Anwita Biosciences Inc

History

ARTICLE ABSTRACT

Usage metrics

Categories

Keywords

Licence

Exports